Hello! You're looking at a policy document report on Overton
We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.
If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Identifiers
Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with acute circulatory failure
Acta Anaesthesiologica Scandinavica
Background Adult critically ill patients often suffer from acute circulatory failure and those with low cardiac output may be treated with inotropic agents. The aim of this Scandinavian Society of Anaesthesiology and Intensive Care Medicine guideline was to present patient‐important treatment recommendations on this topic. Methods This guideline was developed according to GRADE. We assessed the following subpopulations of patients with shock: (1) shock in general, (2) septic shock, (3) cardiogenic shock, (4) hypovolemic shock, (5) shock after cardiac surgery, and (6) other types of shock, including vasodilatory shock. We assessed patient‐important outcome measures, including mortality and serious adverse reactions. Results For all patients, we suggest against the routine use of any inotropic agent, including dobutamine, as compared to placebo/no treatment (very low quality of evidence). For patients with shock in general, and in those with septic and other types of shock, we suggest using dobutamine ra...
Topics in this document
Clinical medicine
Medical specialties
Risk
Dobutamine
Randomized controlled trial
Sepsis
Anesthesiology
Levosimendan
Intensive care medicine
Myocardial infarction
Placebo
Heart failure
Cardiogenic shock
Hypovolemic shock
Meta-analysis
Acute kidney injury
Systematic review
Vasodilatory shock
Medical guideline
Cochrane (organisation)
Shock (circulatory)
Medicine
Cardiovascular system
Health care
Health
Health sciences
Milrinone
Medical emergencies
Heart
Defined daily dose
Cites research funded by
Citations
Cited by 10
other policy documents
(8 of them are from other policy sources)
Recognized names mentioned in this document
Overton only tracks names from certain institutions. Names must have been cited in at least one policy document and their corresponding affiliation has to be found nearby - you can find more details on the help page.
E. Junttila
at Tampere University